Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The determinants of depression in a Romanian cohort of multiple sclerosis patients.
Why does multiple sclerosis only affect human primates?
Exome and regulatory element sequencing of neuromyelitis optica patients.
Personalization of multiple sclerosis treatments: using the chelation therapy approach.
Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
Exercising away the blues: can it help multiple sclerosis-related depression?
Central auditory processing and word discrimination in patients with multiple sclerosis.
Multiple Sclerosis and Fatigue: Understanding the Patient's Needs.
Antibody biomarkers in CNS demyelinating diseases - a long and winding road.
Use of Fingolimod in the Management of Relapsing-Remitting Multiple Sclerosis: Experience from Latin America.
Epstein-Barr virus in multiple sclerosis.
Neurosarcoidosis mimicking multiple sclerosis successfully treated with methotrexate and adalimumab.
Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study.
Feasibility and Findings from a Novel Working Memory fMRI Paradigm in Multiple Sclerosis.
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis.
The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis.
[Corticotherapy and suicidal behavior: A case report].
Physiological Role of K(+) Channels in the Regulation of T Cell Function.
Neurofilament ELISA validation.
Multiple sclerosis increases the risk of infections resulting in a hospitalization among veterans.
EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
The Neurophysiologist Perspective into MS Plasticity.
High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin-4 competing with NMO-IgG.
Mucosal-Associated Invariant T Cells in Multiple Sclerosis: The Jury is Still Out.
Multiple sclerosis and pregnancy; What a neurologist may be asked for?
Pages
« first
‹ previous
…
605
606
607
608
609
610
611
612
613
…
next ›
last »